Postoperative long-term survival of non-small cell lung cancer patients with skip-N2 metastases-Reference-Cited by-同舟云学术

Postoperative long-term survival of non-small cell lung cancer patients with skip-N2 metastases

Published:2021-09 Issue: Volume:38 Page:101505
ISSN:0960-7404
Container-title:Surgical Oncology
language:en
Short-container-title:Surgical Oncology

Author:

Schlachtenberger Georg^ORCID,Doerr Fabian,Menghesha Hruy,Heldwein Matthias B.^ORCID,Hagmeyer Lars,Michel Maximilian,Schaefer Stephan C.,Wahlers Thorsten,Hekmat Khosro

Publisher

Elsevier BV

Subject

Oncology,Surgery

Reference30 articles.

1. Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition);Robinson;Chest,2007

2. ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer;Lardinois;Eur. J. Cardio. Thorac. Surg.,2006

3. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial;Albain;Lancet,2009

4. Prognostic factors after complete resection of pN2 non-small cell lung cancer;Sonobe;J. Thorac. Cardiovasc. Surg.,2013

5. Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Planchard;Ann. Oncol.,2018

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Do skip-N2 metastases significantly impact overall survival and disease-free interval in N2 non-small-cell lung cancer patients? A multicentre analysis;European Journal of Cardio-Thoracic Surgery;2023-06-27

2. Prognostic impact of lymph node spreading pattern in N2 NSCLC patients;Expert Review of Anticancer Therapy;2023-02-03

3. Sublobar resection without staging and lymphadenectomy for ≤2 cm Non-Small Cell Lung Cancer is no adequate therapy;Surgical Oncology;2022-09

4. Different pulmonary adenocarcinoma growth patterns significantly affect survival;Surgical Oncology;2022-03